top of page
Pancreatic cancer
A program led by Dr. Eduard Gratacós
The goal is to develop new therapies to treat pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive forms of cancer, by inhibiting RAF1 and STAT3 proteins to stop tumor progression.
This innovative approach has the potential to improve survival rates for patients with this disease by offering more effective and less toxic therapeutic options.
#Health- Oncological biotechnology
#SDG - 3 y 9
Technical sheet
Interested?
661 227 036
If you would like more information about the research and opportunities to get involved, either through investment or philanthropy, we would be happy to assist you personally.
bottom of page